Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000543300 | SCV000626555 | likely benign | Glycogen storage disease, type II | 2024-12-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000543300 | SCV002780230 | uncertain significance | Glycogen storage disease, type II | 2021-07-23 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003144317 | SCV003828489 | uncertain significance | not provided | 2021-11-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003144317 | SCV005848357 | uncertain significance | not provided | 2024-08-16 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 19343043, 22253258) |
Natera, |
RCV000543300 | SCV001455434 | uncertain significance | Glycogen storage disease, type II | 2019-10-28 | no assertion criteria provided | clinical testing |